U
OTIC

UBS’s Otonomy, Inc. OTIC Stock Holding History

UBS’s Portfolio OTIC Stock Details OTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$5K Buy
+194
New +$3.83K ﹤0.01% 9508

Other funds holding OTIC

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

UBS's OTIC Position: Q3 2014 in Review

UBS opened a new position in Otonomy, Inc. (OTIC) in Q3 2014: 194 shares worth $5K. The stake represents ﹤0.01% of the portfolio and ranks #9508 among its holdings.

50 funds tracked by Wall St. Rank hold OTIC as of Q3 2014.

  • UBS held 194 shares of Otonomy, Inc. worth $5K as of Q3 2014.
  • Otonomy, Inc. was a new UBS position in Q3 2014.
  • Otonomy, Inc. made up ﹤0.01% of UBS's portfolio in Q3 2014, its #9508 holding.
  • 50 funds tracked by Wall St. Rank held Otonomy, Inc. as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.